Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07325513 · ClinicalTrials.gov registry record · NA

Machine Learning in Guiding rTMS Treatment for GWI-Related Headaches and Body Pain

A NA study, sponsored by Veterans Medical Research Foundation.

Recruiting
Registry status
NA
Development phase
140
Enrollment target

NCT07325513 is a NA study that is actively recruiting participants, run by Veterans Medical Research Foundation. The registered enrollment target is 140 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07325513, a NA study, is actively recruiting participants, sponsored by Veterans Medical Research Foundation.

RECRUITING
Registry status
NA
Development phase
140 participants
Enrollment target

Study Summary

The goal of this clinical trial is to create a machine learning algorithm to improve active repetitive transcranial magnetic stimulation (rTMS) treatments for veterans and/or active military personnel by alleviating Gulf War Illness related headaches and body pain (GWI-HAP). This study aims to develop and validate a Support Vector Machine (SVM) model that could replace the trial-and-error process by assessing functional connectivity provided by resting state functional magnetic resonance imaging (rs-fMRI) data to predict the most effective rTMS protocol for each person. All participants will be receiving active rTMS treatment. The main questions it intends to answer are: 1. Does the SVM model predict a more effective treatment response rate for predicted respondents undergoing active rTMS at the left dorsolateral prefrontal cortex (DLPFC) compared to predicted non-respondents? 2. Does the SVM model predict a more effective treatment response rate while undergoing active rTMS at the left dorsolateral prefrontal cortex (DLPFC) and left motor cortex (LMC) in predicted respondents compared to predicted non-respondents? Participants will undergo the following: 1. Receive a total of 13 active rTMS treatment sessions over 3-4 months. 2. Visit the clinic for a total of 15 visits for assessments, check ups, and treatments. 3. Keep a daily log of their headaches, muscle and joint pain throughout the study.

Interventions

  • DEVICE Active Repetitive Transcranial Magnetic Stimulation

Trial Details

FieldValue
Enrollment Target 140 participants
Start Date 2026-03-25
Est. Completion 2029-10
Phase NA

What the Registry Record Tells You About NCT07325513

The ClinicalTrials.gov registry entry for NCT07325513 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 140 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Veterans Medical Research Foundation, which has 35 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Active Repetitive Transcranial Magnetic Stimulation is the first listed.

NCT07325513 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT07325513 about?

NCT07325513 is a clinical study titled "Machine Learning in Guiding rTMS Treatment for GWI-Related Headaches and Body Pain". The goal of this clinical trial is to create a machine learning algorithm to improve active repetitive transcranial magnetic stimulation (rTMS) treatments for veterans and/or active military personnel by alleviating Gulf War Illness related headaches and body pain (GWI-HAP). This study aims to devel...

What is the current status of trial NCT07325513?

This trial is currently recruiting. It is a NA study. The enrollment target is 140 participants. The study started on 2026-03-25. Estimated completion is 2029-10.

What interventions are being tested in trial NCT07325513?

The interventions under investigation include: Active Repetitive Transcranial Magnetic Stimulation (DEVICE).

Who is sponsoring clinical trial NCT07325513?

This trial is sponsored by Veterans Medical Research Foundation, which has 35 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.